{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:20:10Z","timestamp":1774408810245,"version":"3.50.1"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aims to investigate the causal relationship between Alzheimer\u2019s Disease (AD) and Diabetic Retinopathy (DR).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Employing Mendelian Randomization (MR), Generalized Summary-data-based Mendelian Randomization (GSMR), and the MR-Steiger test, this study scrutinizes the genetic underpinnings of the hypothesized causal association between AD and DR, as well as its Proliferative DR (PDR) and Non-Proliferative DR (NPDR) subtypes. Comprehensive data from Genome-Wide Association Studies (GWAS) were analyzed, specifically AD data from the Psychiatric Genomics Consortium (71,880 cases\/383,378 controls), and DR, PDR, and NPDR data from both the FinnGen consortium (FinnGen release R8, DR: 5,988 cases\/314,042 controls; PDR: 8,383 cases\/329,756 controls; NPDR: 3,446 cases\/314,042 controls) and the IEU OpenGWAS (DR: 14,584 cases\/176,010 controls; PDR: 8,681 cases\/204,208 controls; NPDR: 2,026 cases\/204,208 controls). The study also incorporated Functional Mapping and Annotation (FUMA) for an in-depth analysis of the GWAS results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The MR analyses revealed that genetic susceptibility to AD significantly increases the risk of DR, as evidenced by GWAS data from the FinnGen consortium (OR: 2.5090; 95% confidence interval (CI):1.2102-5.2018, false discovery rate P-value (<jats:italic>P<jats:sub>FDR<\/jats:sub><\/jats:italic>)=0.0201; GSMR: b<jats:sub>xy<\/jats:sub>=0.8936, b<jats:sub>xy_se<\/jats:sub>=0.3759, <jats:italic>P<\/jats:italic>=0.0174), NPDR (OR: 2.7455; 95% CI: 1.3178-5.7197, <jats:italic>P<jats:sub>FDR<\/jats:sub><\/jats:italic>=0.0166; GSMR: b<jats:sub>xy<\/jats:sub>=0.9682, b<jats:sub>xy_se<\/jats:sub>=0.3802, <jats:italic>P<\/jats:italic>=0.0126), and PDR (OR: 2.3098; 95% CI: 1.2411-4.2986, <jats:italic>P<jats:sub>FDR<\/jats:sub><\/jats:italic>=0.0164; GSMR: b<jats:sub>xy<\/jats:sub>=0.7962, b<jats:sub>xy_se<\/jats:sub>=0.3205, <jats:italic>P<\/jats:italic>=0.0129) using DR GWAS from FinnGen consortium. These results were corroborated by DR GWAS datasets from IEU OpenGWAS. The MR-Steiger test confirmed a significant association of all identified instrumental variables (IVs) with AD. While a potential causal effect of DR and its subtypes on AD was identified, the robustness of these results was constrained by a low power value. FUMA analysis identified OARD1, NFYA, TREM1 as shared risk genes between DR and AD, suggesting a potential genetic overlap between these complex diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study underscores the contribution of AD to an increased risk of DR, as well as NPDR and PDR subtypes, underscoring the necessity of a holistic approach in the management of patients affected by these conditions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1340608","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T13:08:06Z","timestamp":1713445686000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Alzheimer\u2019s disease as a causal risk factor for diabetic retinopathy: a Mendelian randomization study"],"prefix":"10.3389","volume":"15","author":[{"given":"Fu","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaxin","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur J Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13480","article-title":"Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy","volume":"12","author":"Lin","year":"2021","journal-title":"J Diabetes Investig"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to vision 2020: the right to sight: an analysis for the global burden of disease study","volume":"9","author":"Adelson","year":"2021","journal-title":"Lancet Glob Health"},{"key":"B4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41574-020-00451-4","article-title":"Current understanding of the molecular and cellular pathology of diabetic retinopathy","volume":"17","author":"Antonetti","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tem.2021.10.008","article-title":"Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline","volume":"33","author":"Little","year":"2022","journal-title":"Trends Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108498","article-title":"Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathy","volume":"187","author":"Rolev","year":"2021","journal-title":"Neuropharmacology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21579","article-title":"Cognitive dysfunction: A growing link between diabetes and alzheimer\u2019s disease","volume":"81","author":"Jash","year":"2020","journal-title":"Drug Dev Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and mendelian randomization: A review","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041302","article-title":"Mendelian randomization","volume":"12","author":"Birney","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41467-017-02317-2","article-title":"Causal associations between risk factors and common diseases inferred from GWAS summary data","volume":"9","author":"Zhu","year":"2018","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data","volume":"13","author":"Hemani","year":"2017","journal-title":"PloS Genet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","article-title":"Functional mapping and annotation of genetic associations with fuma","volume":"8","author":"Watanabe","year":"2017","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"Jama"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2020.09.025","article-title":"Herpes simplex virus and alzheimer\u2019s disease: A mendelian randomization study","volume":"99","author":"Kwok","year":"2021","journal-title":"Neurobiol Aging"},{"key":"B15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41437-021-00482-1","article-title":"Linkage disequilibrium under polysomic inheritance","volume":"128","author":"Huang","year":"2022","journal-title":"Heredity (Edinb)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2361","article-title":"Linkage disequilibrium\u2013understanding the evolutionary past and mapping the medical future","volume":"9","author":"Slatkin","year":"2008","journal-title":"Nat Rev Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","article-title":"Evaluating the potential role of pleiotropy in mendelian randomization studies","volume":"27","author":"Hemani","year":"2018","journal-title":"Hum Mol Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32728","article-title":"The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive mendelian randomization study","volume":"77","author":"Xie","year":"2023","journal-title":"Hepatology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/s41588-018-0164-2","article-title":"Publisher correction: detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/eb-2014-101794","article-title":"How to interpret meta-analysis models: fixed effect and random effects meta-analyses","volume":"17","author":"Nikolakopoulou","year":"2014","journal-title":"Evid Based Ment Health"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-022-01174-7","article-title":"Mendelian randomization analyses support causal relationships between brain imaging-derived phenotypes and risk of psychiatric disorders","volume":"25","author":"Guo","year":"2022","journal-title":"Nat Neurosci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(78)90098-X","article-title":"Fitting straight lines when both variables are subject to error","volume":"22","author":"Riggs","year":"1978","journal-title":"Life Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyt179","article-title":"Calculating statistical power in mendelian randomization studies","volume":"42","author":"Brion","year":"2013","journal-title":"Int J Epidemiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004219","article-title":"Magma: generalized gene-set analysis of GWAS data","volume":"11","author":"de Leeuw","year":"2015","journal-title":"PloS Comput Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.10.061","article-title":"A compendium of chromatin contact maps reveals spatially active regions in the human genome","volume":"17","author":"Schmitt","year":"2016","journal-title":"Cell Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224180","article-title":"Decreased retinal thickness in patients with alzheimer\u2019s disease is correlated with disease severity","volume":"14","author":"Kim","year":"2019","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2010.06.020","article-title":"Identification of amyloid plaques in retinas from alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model","author":"Koronyo-Hamaoui","year":"2011","journal-title":"Neuroimage"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2174\/0929867325666180307114332","article-title":"Neurodegenerative process linking the eye and the brain","volume":"26","author":"Mancino","year":"2019","journal-title":"Curr Med Chem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/156720510790274491","article-title":"Alzheimer\u2019s disease and retinal neurodegeneration","volume":"7","author":"Guo","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8538573","article-title":"Ocular manifestations of alzheimer\u2019s and other neurodegenerative diseases: the prospect of the eye as a tool for the early diagnosis of alzheimer\u2019s disease","volume":"2018","author":"Colligris","year":"2018","journal-title":"J Ophthalmol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s40478-018-0650-x","article-title":"Amyloid-beta and phosphorylated tau in post-mortem alzheimer\u2019s disease retinas","volume":"6","author":"den Haan","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.1578","article-title":"Association of retinal nerve fiber layer thinning with current and future cognitive decline: A study using optical coherence tomography","volume":"75","author":"Ko","year":"2018","journal-title":"JAMA Neurol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2337\/db10-0752","article-title":"Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study","volume":"59","author":"Ding","year":"2010","journal-title":"Diabetes"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3233\/jad-132570","article-title":"Severe diabetic retinal disease and dementia risk in type 2 diabetes","author":"Exalto","year":"2014","journal-title":"J Alzheimer\u2019s disease: JAD"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3233\/jad-215313","article-title":"Diabetic retinopathy predicts risk of alzheimer\u2019s disease: A Danish registry-based nationwide cohort study","volume":"86","author":"Pedersen","year":"2022","journal-title":"J Alzheimer\u2019s disease: JAD"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2022.12.003","article-title":"Diabetic retinopathy and dementia association, beyond diabetes severity","volume":"249","author":"Lee","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2021.101139","article-title":"Non-proliferative diabetic retinopathy","volume":"67","author":"Danek","year":"2021","journal-title":"Dis Mon"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2022.101151","article-title":"Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis","volume":"94","author":"Padovani-Claudio","year":"2023","journal-title":"Prog Retin Eye Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2013.51","article-title":"Deficiency of terminal ADP-ribose protein glycohydrolase targ1\/C6orf130 in neurodegenerative disease","volume":"32","author":"Sharifi","year":"2013","journal-title":"EMBO J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.276238","article-title":"Orphan macrodomain protein (Human C6orf130) is an O-acyl-ADP-ribose deacylase: solution structure and catalytic properties","volume":"286","author":"Peterson","year":"2011","journal-title":"J Biol Chem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2521","article-title":"Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases","volume":"20","author":"Rosenthal","year":"2013","journal-title":"Nat Struct Mol Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1042\/0264-6021:3550019","article-title":"Identification of the G13 (Camp-response-element-binding protein-related protein) gene product related to activating transcription factor 6 as a transcriptional activator of the mammalian unfolded protein response","volume":"355","author":"Haze","year":"2001","journal-title":"Biochem J"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkh692","article-title":"Human P32, interacts with B subunit of the CCAAT-binding factor, CBF\/NF-Y, and inhibits CBF-mediated transcription activation in vitro","volume":"32","author":"Chattopadhyay","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(91)90070-U","article-title":"One subunit of the transcription factor NF-Y maps close to the major histocompatibility complex in murine and human chromosomes","volume":"11","author":"Li","year":"1991","journal-title":"Genomics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.pharmthera.2017.02.043","article-title":"Trem-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives","volume":"177","author":"Tammaro","year":"2017","journal-title":"Pharmacol Ther"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101124","article-title":"Trem receptors connecting bowel inflammation to neurodegenerative disorders","volume":"8","author":"Natale","year":"2019","journal-title":"Cells"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1622-5","article-title":"Trem1 facilitates microglial phagocytosis of amyloid beta","volume":"132","author":"Jiang","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12974-022-02582-z","article-title":"The associations between plasma soluble trem1 and neurological diseases: A mendelian randomization study","volume":"19","author":"Shi","year":"2022","journal-title":"J Neuroinflamm"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1111","article-title":"Prevalence of diabetic retinopathy in the United States, 2005-2008","volume":"304","author":"Zhang","year":"2010","journal-title":"JAMA"},{"key":"B55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12020-018-1697-y","article-title":"The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: A meta-analysis","volume":"62","author":"Cai","year":"2018","journal-title":"Endocrine"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004135","article-title":"Healthy lifestyle behaviors, mediating biomarkers, and risk of microvascular complications among individuals with type 2 diabetes: A cohort study","volume":"20","author":"Geng","year":"2023","journal-title":"PloS Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11892-019-1186-6","article-title":"Genetics of diabetic retinopathy","volume":"19","author":"Han","year":"2019","journal-title":"Curr Diabetes Rep"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1340608\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T13:08:09Z","timestamp":1713445689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1340608\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":57,"alternative-id":["10.3389\/fendo.2024.1340608"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1340608","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,18]]},"article-number":"1340608"}}